Brought to you by 
Shire buys US neurological pharma company Richwood
13 Jul 1999
Executive Summary
UK company Shire Pharmaceuticals increased its US presence, buying Richwood (neurological drugs) for $160mm--$145mm in stock and $15mm in debt. Earlier this year Shire bought another US pharmaceutical company, Pharmavene.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Shire buys US neurological pharma company Richwood
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice